Historical record - last NADAC effective date: 8/18/2021
Product Information
LEVOCETIRIZINE 5 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.1934 per EA under NDC 43598073590. Its NADAC has been published 111 times since Jul 24, 2019.
FDA first approved this application on Jan 19, 2018.
Strength
5 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598073590
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
8/18/2021
Active Ingredients
LEVOCETIRIZINE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210375FDA Approved
1/19/2018
On Market Since
3/12/2018
Pharmacological Classes
Price Statistics
The NADAC for LEVOCETIRIZINE 5 MG TABLET has been published 111 times since Jul 24, 2019, and over the history we have for it it has declined 25.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1934 per EA |
|---|---|
| All-time high | $0.2635 (Apr 15, 2020) |
| All-time low | $0.1329 (Apr 21, 2021) |
| Median price | $0.1992 |
| Average price | $0.1990 |
| Largest weekly change | +43.7% (May 19, 2021) |
| Weeks tracked | 111 |
| Tracking since | Jul 24, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-25.9%
Last surveyed Sep 1, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 74% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
levocetirizine dihydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVOCETIRIZINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVOCETIRIZINE 5 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $0.1934 per EA (NDC 43598073590), effective Sep 1, 2021.
How has the price of LEVOCETIRIZINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVOCETIRIZINE 5 MG TABLET has declined 25.9%. It has been tracked across 111 weekly CMS publications since Jul 24, 2019.
What are the highest and lowest recorded NADAC prices for LEVOCETIRIZINE 5 MG TABLET?
Since Jul 24, 2019, the NADAC for LEVOCETIRIZINE 5 MG TABLET has ranged from a low of $0.1329 (Apr 21, 2021) to a high of $0.2635 (Apr 15, 2020), with a median of $0.1992 per EA.
Are there cheaper alternatives to LEVOCETIRIZINE 5 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVOCETIRIZINE 5 MG TABLET, is $0.0511 per EA — about 74% below LEVOCETIRIZINE 5 MG TABLET.
Who manufactures LEVOCETIRIZINE 5 MG TABLET?
LEVOCETIRIZINE 5 MG TABLET (NDC 43598073590) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.